Australians Develop Treatment To Help Immune System Fight AIDS
This article was originally published in PharmAsia News
Australian researchers report that a treatment using overlapping peptide-pulsed autologous cells appears be able to train immune system cells to do a better job of recognizing the AIDS virus. The scientists wrote in a professional journal that tests on monkeys with a similar virus showed the OPAL treatment was effective in controlling the infection. They said, however, the treatment does not cure AIDS. The treatment mixes a patient's blood cells with minute amounts of protein from the virus to do the work. (Click here for more
You may also be interested in...
The China National Biotec Group has filed the first application in China for the broad use of a COVID-19 vaccine, days after the national regulatory agency released review guidelines for the conditional approval of such products.
More patent-related turbulence appears ahead for Novartis’s sacubitril/valsartan combination in India, with Torrent emerging as the new challenger. The companies are engaged in a legal battle and the Indian firm is also seeking a revocation of the patent on the star heart failure treatment.
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.